Laverne Baulch's profile photo

Laverne Baulch

Featured in: Favicon ajp.com.au

Articles

  • Sep 19, 2024 | ajp.com.au | Nicholas O’Donoghue |Geoffrey Timbs |JOhn Smith |John Smith |Laverne Baulch

    NIP-funded RSV vaccine for women in late-stage pregnancy on the horizon  Talks between the government and Pfizer to deliver a National Immunisation Program (NIP) funded respiratory syncytial virus (RSV) vaccine for women in late-stage pregnancy are close to a conclusion, Mark Butler the Minister for Health and Aged Care says. Speaking at a press conferenceThis content is restricted to registered users only.

  • Sep 19, 2024 | ajp.com.au | Megan Haggan |JOhn Smith |John Smith |Laverne Baulch |Michael Khoo

    What do patients think about pharmacy students taking on the work of obtaining best possible medication histories? Researchers have looked into whether pharmacy students undertaking clinical placements could perform the “time-consuming” work of taking BPMHs – and noted that they could be an efficient alternative. But one group of researchers have identified that there isThis content is restricted to registered users only.

  • Sep 19, 2024 | ajp.com.au | Megan Haggan |JOhn Smith |John Smith |Laverne Baulch |Michael Khoo

    Could a tool used to identify the risk of hospital readmission amongst metropolitan patients work for rural patients too? Researchers from the University of Sydney have looked into validating a tool initially developed  to  identify patients at high risk of readmission from a metropolitan hospital to a rural setting. Linda Krogh, Shania Liu, Stephen Carter,This content is restricted to registered users only.

  • Sep 19, 2024 | ajp.com.au | Kate Cowling |Laverne Baulch |Michael Khoo |Geoffrey Timbs

    As the market awaits the ACCC’s merger ruling, investors have been loading up on Sigma shares, leading to one online analyst to list the wholesaler as the most “overbought” ASX 200 stock Sigma Healthcare’s share price hit an eight-year high this week, prompting questions about whether the market is backing in an approved merger betweenThis content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

  • Aug 24, 2024 | ajp.com.au | Philip Smith |James Tsaoucis |Laverne Baulch |Vincent Chua

    While many in pharmacy are sceptical, or even scared, about the rise of artificial intelligence, Robert Sztar says it should be able to improve many aspects of business management  Scrolling through LinkedIn recently, I found an intriguing title: "Artificial Intelligence Beyond the Hype." This statement led me to reflect on the general sentiment towards AIThis content is restricted to registered users only.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →